Brewer Alexander, Hanna Cathy, Eckmann Lynne, Schadler Aric, Divine Holly
J Am Pharm Assoc (2003). 2018 Jul-Aug;58(4S):S69-S72.e1. doi: 10.1016/j.japh.2018.04.031.
To determine patients' awareness of the screening recommendations for hepatitis C virus (HCV) in "Baby Boomers," to assess patients' willingness to receive a point-of-care HCV screening test in the pharmacy, and to determine patients' barriers to receiving a point-of-care HCV screening test in a community pharmacy.
An anonymous 12-question survey was developed. Five shareholder pharmacies of American Pharmacy Services Corporation (APSC) volunteered to participate. Surveys were mailed to participating pharmacies with instructions to distribute to patients born in 1945 to 1965 at the pharmacy point-of-sale. Data were collected over a 12-week period from October 2016 to January 2017. Completed surveys were collected by participating pharmacies and mailed to the primary investigator. Data were analyzed with the use of descriptive statistics.
Ninety-five eligible surveys were returned and analyzed. A majority of respondents were female (63.00%) and held a bachelor degree or higher (63.16%); 38.95% of patients were aware of HCV age-based risk factors and screening recommendations. Only 9.80% of patients were aware of the fingerstick point-of-care testing (POCT) option for HCV. Nearly three-fourths (71.70%) were willing to receive POCT at a community pharmacy. A majority of patients (65.52%) were unwilling to pay an amount that would cover the cost of testing. Descriptive statistics, including a Pearson chi-square test, were used to analyze the data. Significant differences in the distribution of the percentages of people willing to receive testing and to pay for testing were found among levels of annual household income.
A majority of patients are willing to receive POCT at a community pharmacy. Patients were unwilling to pay for testing, however, so pharmacies looking to offer point-of-care HCV screening would need to secure further financial resources, such as insurance reimbursement or grant funding, for this service to be financially feasible.
确定患者对“婴儿潮一代”丙型肝炎病毒(HCV)筛查建议的知晓情况,评估患者在药房接受即时检测HCV筛查的意愿,并确定患者在社区药房接受即时检测HCV筛查的障碍。
设计了一份包含12个问题的匿名调查问卷。美国药房服务公司(APSC)的5家股东药房自愿参与。调查问卷被邮寄至参与的药房,并附有指示,要求在药房销售点分发给1945年至1965年出生的患者。数据收集时间为2016年10月至2017年1月的12周内。参与的药房收集完成的调查问卷,并邮寄给主要研究者。使用描述性统计方法对数据进行分析。
共返回并分析了95份合格调查问卷。大多数受访者为女性(63.00%),拥有学士学位或更高学历(63.16%);38.95%的患者知晓基于年龄的HCV风险因素和筛查建议。只有9.80%的患者知晓HCV的即时检测(POCT)指尖采血选项。近四分之三(71.70%)的患者愿意在社区药房接受POCT检测。大多数患者(65.52%)不愿意支付检测费用。使用描述性统计方法,包括Pearson卡方检验,对数据进行分析。发现不同家庭年收入水平的人群在接受检测和支付检测费用的意愿百分比分布上存在显著差异。
大多数患者愿意在社区药房接受POCT检测。然而,患者不愿意支付检测费用,因此希望提供即时检测HCV筛查的药房需要获得进一步资金,如保险报销或赠款资助,以使这项服务在财务上可行。